TRILLIUM ASSET MANAGEMENT, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRILLIUM ASSET MANAGEMENT, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$572,000
-41.5%
6,005
-31.4%
0.02%
-42.9%
Q2 2020$978,000
+50.5%
8,748
-2.1%
0.04%
+23.5%
Q1 2020$650,000
-30.4%
8,932
-0.3%
0.03%
-19.0%
Q4 2019$934,000
-0.7%
8,957
-5.2%
0.04%
-4.5%
Q3 2019$941,000
-11.9%
9,451
+1.0%
0.04%
-15.4%
Q2 2019$1,068,000
+3.1%
9,355
+13.5%
0.05%0.0%
Q1 2019$1,036,000
+74.1%
8,245
+88.0%
0.05%
+52.9%
Q4 2018$595,000
-48.6%
4,386
+4.1%
0.03%
-41.4%
Q3 2018$1,157,000
+27.8%
4,215
-3.5%
0.06%
+20.8%
Q2 2018$905,000
+24.7%
4,370
-0.5%
0.05%
+20.0%
Q1 2018$726,000
+16.2%
4,394
-3.7%
0.04%
+17.6%
Q4 2017$625,000
+0.5%
4,562
-0.2%
0.03%
-5.6%
Q3 2017$622,000
+13.5%
4,570
+1.3%
0.04%
+9.1%
Q2 2017$548,000
+20.2%
4,511
+4.7%
0.03%
+13.8%
Q1 2017$456,000
+14.3%
4,309
+9.7%
0.03%
+11.5%
Q4 2016$399,000
+9.3%
3,929
+9.8%
0.03%
+13.0%
Q3 2016$365,0003,5790.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders